Zinplava
Chemical Name | bezlotoxumab |
Dosage Form | Injection (intravenous; 1000 ml/40 mL) |
Drug Class | Monoclonal antibodies |
System | Digestive |
Company | Merck & Co. |
Approval Year | 2016 |
Indication
- To reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older who are receiving antibacterial drug treatment of CDI and are at a high risk for CDI recurrence.